Optimising metastic renal cell carcinoma (mRCC): Treatment lessons from the real world: Introduction

Additional treatment options impact first-line treatment of mRCC: No

Current treatment options in mRCC

Discussion: Additional treatment options impact first-line treatment of mRCC

Additional treatment options impact first-line treatment of mRCC: Yes

What have we learned? Expert perspectives

From clinical trial to clinical practice: Evidence from the real world

Gene targeting in kidney cancer treatment

Surgical strategies available for renal cell carcinoma with inferior vena cava invasion

Use of robotics in kidney cancer surgery

Work and history of the Kidney Cancer Association

Intratumour heterogeneity in renal and lung cancer

Kidney cancer treatment ten years from now